Anzeige
❌
Mehr »
Login
Freitag, 28.03.2025 Börsentäglich über 12.000 News von 693 internationalen Medien
Trump-Dekret entfesselt Kupfer-Boom - ist DAS der nächste +2.000?%-Explorer?
Anzeige

Indizes
Kurs
%		News
24 h / 7 T		Aufrufe
7 Tage

Aktien
Kurs
%		News
24 h / 7 T		Aufrufe
7 Tage

Xetra-Orderbuch

Fonds
Kurs
%

Devisen
Kurs
%

Rohstoffe
Kurs
%

Themen
Kurs
%

Erweiterte Suche

WKN: A40GN1 | ISIN: CA4229102088 | Ticker-Symbol: HBP0
Frankfurt
27.03.25
08:08 Uhr
0,436 Euro
0,000
0,00 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
HELIX BIOPHARMA CORP Chart 1 Jahr
5-Tage-Chart
HELIX BIOPHARMA CORP 5-Tage-Chart

Aktuelle News zur HELIX BIOPHARMA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
HELIX BIOPHARMA Aktie jetzt für 0€ handeln
MiHelix BioPharma Corp (2): Helix BioPharma holders approve all matters at AGSM1Stockwatch
MiHelix BioPharma Corp. Announces Voting Results from its Annual General and Special Meeting1TheNewswire
18.03.Helix BioPharma Corp. Announces Filing of Interim Financial Statements as of and for the Three and Six Month Periods Ended January 31, 20252TheNewswire
11.03.Helix BioPharma Corp (2): Helix's L-DOS47 presentation to be held March 121Stockwatch
11.03.Helix BioPharma Corp. Announces Upcoming Poster Presentation at the 20th European Molecular Imaging Meeting in Bilbao, Spain2TheNewswire
06.03.Helix BioPharma Corp (2): Helix BioPharma adds Guggi as CTO, Mehrling as CMO1Stockwatch
06.03.Helix BioPharma Corp.: Helix Biopharma Corp. Expands Leadership Team with World-Class Oncology and Scientific Experts2TheNewswire
04.03.Helix BioPharma Corp (2): Helix BioPharma extends AGSM date to March 262Stockwatch
03.03.Helix BioPharma Corp. receives approval for the Extension of Annual General and Special Meeting to Seek Approval of Asset Acquisitions and Proposed Financing1TheNewswire
24.02.Helix BioPharma Corp. Extends Date of Annual General and Special Meeting to Seek Approval of Asset Acquisitions and Proposed Financing5TheNewswire
22.02.Helix BioPharma Corp (2): Helix BioPharma pushes AGSM date to March 264Stockwatch
10.01.Helix BioPharma Corp (2): Helix BioPharma closes $3-million private placement8Stockwatch
10.01.Helix BioPharma Corp.: Helix Biopharma Corp. Announces Closing of Private Placement of Common Shares3TheNewswire
11.12.24Helix BioPharma Corp. Appoints James B. Murphy as Chief Financial Officer6TheNewswire
11.12.24Helix Biopharma appoints James Murphy as CFO2Seeking Alpha
07.12.24Helix BioPharma Corp (2): Helix BioPharma tweaks Laevoroc agreements6Stockwatch
06.12.24Helix BioPharma Corp.: Helix BioPharma Amends Acquisition Agreements to Finalise Share Consideration Ahead of Potential Financing1TheNewswire
03.12.24Helix BioPharma Corp (2): Helix to acquire Laevoroc, Gemceda for shares3Stockwatch
03.12.24Helix BioPharma Corp.: Helix Biopharma Corp. Enters into Asset Purchase Agreement to Acquire Oral Gemcitabine Chemotherapy Compound71TheNewswire
29.11.24Helix BioPharma Corp.: Helix Biopharma Corp. Enters into Asset Purchase Agreement to Acquire Oral Immune Checkpoint Inhibitor and Expand Immune-Oncology Portfolio2TheNewswire
Seite:  1 2 Weiter >>
33 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1